Werkgroep Cardiologische centra Nederland

PARALLAX (Follow-up)

A 24-week, study to evaluate the effect of LCZ696 on NT-proBNP, symptoms, exercise function and safety compared to individualized medical management of comorbidities in patients with heart failure and preserved ejection fraction
Medicine
Entresto
Population
Heart failure
Phase
III
Starting year
2017